Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor
Crossref DOI link: https://doi.org/10.1007/s40262-017-0543-3
Published Online: 2017-04-17
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ayalasomayajula, Surya
Langenickel, Thomas
Pal, Parasar
Boggarapu, Sreedevi
Sunkara, Gangadhar
Funding for this research was provided by:
Novartis
License valid from 2017-04-17